Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanislas Ropert

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|April 13, 2011
A painful cranial bulgeRomain Coriat, Olivier Mir, Stanislas Ropert, et al.
The Lancet. Oncology|August 7, 2007
CYP3A4/5 and pharmacogenetics in patients with sarcomaOlivier Mir, Stanislas Ropert, Jérôme Alexandre, et al.
Investigational New Drugs|July 13, 2010
Reactivation of tuberculosis during temsirolimus therapyRomain Coriat, Olivier Mir, Stanislas Ropert, et al.
Investigational New Drugs|December 19, 2017
Everolimus induced mood changes in breast cancer patients: a case-control studyOlivier Mir, Alexandre Salvador, Sarah Dauchy, et al.
Investigational New Drugs|February 24, 2010
Avascular necrosis of the femoral head: a rare class-effect of anti-VEGF agentsOlivier Mir, Romain Coriat, Thomas Gregory, et al.
BMC Cancer|June 11, 2014
Inaugural bone metastases in non-small cell lung cancer: a specific prognostic entity?Mélanie Deberne, Stanislas Ropert, Bertrand Billemont, et al.
Inflammatory Bowel Diseases|June 16, 2011
Feasibility of anti-VEGF agent bevacizumab in patients with Crohn's diseaseRomain Coriat, Olivier Mir, Sarah Leblanc, et al.
Anti-Cancer Drugs|February 12, 2009
Vinorelbine and oxaliplatin in stage IV nonsmall cell lung cancer patients unfit for cisplatin: a single-center experienceOlivier Mir, Jérôme Alexandre, Stanislas Ropert, et al.
Journal of Thoracic Disease|June 11, 2019
Four-arm robotic lung resection versus muscle-sparing mini-thoracotomy: retrospective experienceMarion Durand, Elias Dabboura, Laurent Lamonerie, et al.
Cancer Chemotherapy and Pharmacology|September 8, 2010
Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumorsErich Brendel, Matthias Ludwig, Chetan Lathia, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|April 13, 2011
A painful cranial bulgeRomain Coriat, Olivier Mir, Stanislas Ropert, et al.
The Lancet. Oncology|August 7, 2007
CYP3A4/5 and pharmacogenetics in patients with sarcomaOlivier Mir, Stanislas Ropert, Jérôme Alexandre, et al.
Investigational New Drugs|July 13, 2010
Reactivation of tuberculosis during temsirolimus therapyRomain Coriat, Olivier Mir, Stanislas Ropert, et al.
Investigational New Drugs|December 19, 2017
Everolimus induced mood changes in breast cancer patients: a case-control studyOlivier Mir, Alexandre Salvador, Sarah Dauchy, et al.
Investigational New Drugs|February 24, 2010
Avascular necrosis of the femoral head: a rare class-effect of anti-VEGF agentsOlivier Mir, Romain Coriat, Thomas Gregory, et al.
BMC Cancer|June 11, 2014
Inaugural bone metastases in non-small cell lung cancer: a specific prognostic entity?Mélanie Deberne, Stanislas Ropert, Bertrand Billemont, et al.
Inflammatory Bowel Diseases|June 16, 2011
Feasibility of anti-VEGF agent bevacizumab in patients with Crohn's diseaseRomain Coriat, Olivier Mir, Sarah Leblanc, et al.
Anti-Cancer Drugs|February 12, 2009
Vinorelbine and oxaliplatin in stage IV nonsmall cell lung cancer patients unfit for cisplatin: a single-center experienceOlivier Mir, Jérôme Alexandre, Stanislas Ropert, et al.
Journal of Thoracic Disease|June 11, 2019
Four-arm robotic lung resection versus muscle-sparing mini-thoracotomy: retrospective experienceMarion Durand, Elias Dabboura, Laurent Lamonerie, et al.
Cancer Chemotherapy and Pharmacology|September 8, 2010
Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumorsErich Brendel, Matthias Ludwig, Chetan Lathia, et al.
Pageof 6